A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult
Clinical trial NCT04695652 · COMPLETED
Trial details
- NCT number
- NCT04695652
- Sponsor
- Medigen Vaccine Biologics Corp.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2021-05-15
- Enrollment
- 3854
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.